Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISLB 2022 | Highlights of ISLB 2022

Massimo Cristofanilli • 31 Oct 2022
ISLB 2022
General

Massimo Cristofanilli, MD, FACP, Weill Cornell Medicine, New York, NY, discusses the highlights of ISLB 2022, including discussions on clinical applications of liquid biopsy, improvements to future study designs, and the benefit of collaboration among a range of healthcare professionals. This interview took place at the International Society of Liquid Biopsy (ISLB) 2022 congress in Miami, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consultant for: Menarini, Lilly, AZ, Ellipses, Celcuity, Olaris, Sermonix
Grant/Research support from: Pfizer, Lilly, AZ
Honoraria from: Pfizer, Lilly, Foundation Medicine, Guardant

More from Massimo Cristofanilli

3:40
Developments in liquid biopsy for breast cancer over 10 years
Massimo Cristofanilli • 31 Oct 2022
3:07
The role of circulating tumor cell clusters in advanced disease
Massimo Cristofanilli • 31 Oct 2022
5:04
PALOMA-3: palbociclib and fulvestrant for HR-/HER+ metastatic breast cancer
Massimo Cristofanilli • 20 Oct 2018

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals